Camber Capital Management LP Myriad Genetics Inc Transaction History

Camber Capital Management LP

$3.15 Billion
Q3 2024

A detailed history of Camber Capital Management LP transactions in Myriad Genetics Inc stock. As of the latest transaction made, Camber Capital Management LP holds 3,950,000 shares of MYGN stock, worth $52.8 Million. This represents 3.44% of its overall portfolio holdings.

Number of Shares

3,950,000

Previous 5,500,000 28.18%

Holding current value

$52.8 Million

Previous $135 Million 19.58%

% of portfolio

3.44%

Previous 3.72%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.97 - $28.6 $37.2 Million - $44.3 Million	-1,550,000 Reduced 28.18%	3,950,000 $108 Million
Q2 2024 Aug 14, 2024	SELL	$17.98 - $25.47 $38.4 Million - $54.4 Million	-2,135,000 Reduced 27.96%	5,500,000 $135 Million
Q4 2023 Feb 14, 2024	BUY	$13.91 - $21.32 $13.9 Million - $21.3 Million	1,000,000 Added 15.07%	7,635,000 $146 Million
Q2 2023 Aug 14, 2023	SELL	$17.56 - $23.76 $6.41 Million - $8.67 Million	-365,000 Reduced 5.21%	6,635,000 $154 Million
Q4 2022 Feb 14, 2023	BUY	$14.51 - $20.99 $29 Million - $42 Million	2,000,000 Added 40.0%	7,000,000 $102 Million
Q2 2022 Aug 15, 2022	BUY	$16.45 - $25.88 $24.7 Million - $38.8 Million	1,500,000 Added 42.86%	5,000,000 $90.9 Million
Q1 2022 May 16, 2022	BUY	$22.67 - $28.01 $17 Million - $21 Million	750,000 Added 27.27%	3,500,000 $88.2 Million
Q3 2021 Nov 15, 2021	SELL	$29.97 - $36.66 $7.49 Million - $9.17 Million	-250,000 Reduced 8.33%	2,750,000 $88.8 Million
Q1 2021 May 17, 2021	SELL	$19.92 - $31.6 $39.8 Million - $63.2 Million	-2,000,000 Reduced 40.0%	3,000,000 $91.4 Million
Q3 2020 Nov 16, 2020	BUY	$11.25 - $14.75 $11.3 Million - $14.8 Million	1,000,000 Added 25.0%	5,000,000 $65.2 Million
Q2 2020 Aug 14, 2020	BUY	$10.69 - $16.49 $17.6 Million - $27.2 Million	1,650,000 Added 70.21%	4,000,000 $45.4 Million
Q1 2020 May 15, 2020	BUY	$9.78 - $29.53 $13.2 Million - $39.9 Million	1,350,000 Added 135.0%	2,350,000 $33.6 Million
Q3 2019 Nov 14, 2019	BUY	$22.08 - $47.08 $22.1 Million - $47.1 Million	1,000,000 New	1,000,000 $28.6 Million
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $56.4 Million - $75.5 Million	-1,500,000 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$28.45 - $37.14 $14.2 Million - $18.6 Million	-500,000 Reduced 25.0%	1,500,000 $51.5 Million
Q3 2017 Nov 14, 2017	BUY	$24.01 - $36.2 $48 Million - $72.4 Million	2,000,000	2,000,000 $72.4 Million

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.5M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.08B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Camber Capital Management LP with notifications on news.

Account

Camber Capital Management LP Myriad Genetics Inc Transaction History